Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 20.88 as of 2026-09-25T00:15:56.748Z.
Consensus retrieved: 2026-09-13T23:35:28.467Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-25T00:15:56.748Z.
Quote observation: 2026-09-24T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 67a2cc827e0699dc6888b5944af1da3ed3ca3877f7589b0aae861a86d1f718ef
Forward PE Ratio (20.88) = Dated Quote Price ($135.78) / Consensus Forward EPS ($6.50)
FORWARD PE RATIO
20.88
SECTOR MEDIAN · HEALTHCARE
18.75
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+11.36%
vs the sector median at left
Insulet Corp.
Market Cap
$9.40B
Forward PE Ratio
20.88
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Insulet Corp. (PODD) | $9.40B | 20.88 |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 15.88 |
| Globus Medical, Inc. (GMED)vs › | $10.02B | 14.85 |
| Molina Healthcare, Inc. (MOH)vs › | $10.09B | N/A |
| The Ensign Group, Inc. (ENSG)vs › | $10.10B | 22.23 |
| Align Technology, Inc. (ALGN)vs › | $10.43B | 12.90 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.43B | 40.20 |
| Universal Health Services, Inc. (UHS)vs › | $10.71B | 7.86 |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 12.19 |
| DaVita Inc. (DVA)vs › | $11.21B | 11.77 |
Trailing P/E
25.4
reported TTM EPS
Forward P/E
20.9
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $6.50 implies +21.5% EPS growth vs the reported trailing $5.35.
At the dated quote price of $135.78, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $6.50 | $6.44 – $6.54 | 14 | 20.9x |
| 2027-12-31 | $7.71 | $7.51 – $8.02 | 15 | 17.6x |
| 2028-12-31 | $9.28 | $8.95 – $9.75 | 10 | 14.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
